GENinCode Plc (AIM:GENI)
London · Delayed Price · Currency is GBP · Price in GBX 0.9000
+0.0250 (2.86%)
Jun 17, 2026, 4:32 PM GMT
GENinCode Market Cap
GENinCode has a market cap or net worth of 6.97 million as of June 17, 2026. Its market cap has increased by 10.37% in one year.
Market Cap
6.97M
Enterprise Value
6.28M
Revenue
3.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since July 22, 2021, GENinCode's market cap has decreased from 40.72M to 6.97M, a decrease of -82.89%. That is a compound annual growth rate of -30.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 6.59M | -4.30% |
| Dec 31, 2025 | 6.89M | 2.39% |
| Dec 31, 2024 | 6.72M | 33.68% |
| Dec 29, 2023 | 5.03M | -32.26% |
| Dec 30, 2022 | 7.43M | -76.15% |
| Dec 31, 2021 | 31.14M | -23.53% |
| Jul 22, 2021 | 40.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.80B |
| GSK plc | 79.20B |
| Haleon | 29.84B |
| Smith & Nephew | 9.61B |
| Renalytix | 8.30M |
| Oxford BioDynamics | 7.72M |
| OptiBiotix Health | 6.40M |
| CRISM Therapeutics | 5.69M |